Premium
Uniqure NV (0EE0)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Mr. Madhavan BalachandranIndependent Non-Executive Director | -11,69k | 234,68k | Derivative Exercise and Sale | 19,39 - 47,08 | 43,25k | - |
| 2026-06-15 | Mr. Madhavan BalachandranIndependent Non-Executive Director | -10,00k | 193,60k | Derivative Exercise and Sale | 8,49 - 27,85 | 43,25k | - |
| 2026-06-15 | Dr. Jeannette PottsChief Legal & Compliance Officer and Corporate Secretary | -5,24k | 144,91k | Vente | 27,67 | 58,01k | -8,28% |
| 2026-06-11 | Mr. David D. MeekIndependent Chairman of the Board | -1,99k | 53,93k | Vente | 27,06 | 32,20k | -5,83% |
| 2026-06-10 | Dr. Robert GutNon-Executive Director | -4,91k | 127,76k | Automatic Disposition | 26,03 - 26,05 | 24,71k | -16,57% |
| 2026-06-11 | Dr. Robert GutNon-Executive Director | -2,73k | 73,77k | Vente | 27,06 | 24,71k | -9,94% |
| 2026-06-10 | Dr. Robert GutNon-Executive Director | -2,65k | 26,53k | Derivative Exercise and Sale | 16,04 - 26,07 | 24,71k | - |
| 2026-06-11 | Ms. Kylie O'KeefeChief Customer & Strategy Officer | -15,94k | 431,23k | Vente | 27,06 | 108,86k | -12,77% |
| 2026-06-11 | Dr. Jeremy P. SpringhornIndependent Non-Executive Director | -1,99k | 53,93k | Vente | 27,06 | 35,70k | -5,29% |
| 2026-06-11 | Dr. Leonard E. PostIndependent Non-Executive Director | -1,99k | 53,93k | Vente | 27,06 | 27,94k | -6,66% |
| 2026-06-11 | Mr. Jack L. KayeIndependent Non-Executive Director | -1,99k | 53,93k | Vente | 27,06 | 18,45k | -9,75% |
| 2026-06-11 | Ms. Rachelle Suzanne JacquesNon-Executive Director | -1,99k | 53,93k | Vente | 27,06 | 26,35k | -7,03% |
| 2026-06-11 | Mr. Madhavan BalachandranIndependent Non-Executive Director | -1,99k | 53,93k | Vente | 27,06 | 35,70k | -5,29% |
| 2026-06-03 | Mr. Jack L. KayeIndependent Non-Executive Director | -2,65k | 36,95k | Derivative Exercise and Sale | 16,04 - 30,01 | 12,47k | - |
| 2026-05-08 | Dr. Walid Abi-SaabChief Medical Officer | -25,00k | 487,75k | Derivative Exercise and Sale | 5,59 - 25,10 | 169,67k | - |
| 2026-05-08 | Dr. Walid Abi-SaabChief Medical Officer | -20,00k | 500,00k | Automatic Disposition | 25,00 | 169,67k | -10,54% |
| 2026-03-04 | Mr. Matthew Craig KapustaCEO & Executive Director | -14,58k | 132,10k | Vente | 9,06 | 474,06k | -2,98% |
| 2026-03-04 | Dr. Walid Abi-SaabChief Medical Officer | -808,00 | 7,32k | Vente | 9,06 | 189,67k | -0,42% |
| 2026-03-04 | Dr. Jeannette PottsChief Legal & Compliance Officer and Corporate Secretary | -3,41k | 30,91k | Vente | 9,06 | 47,55k | -6,70% |
| 2026-03-04 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -12,00k | 108,72k | Vente | 9,06 | 121,81k | -8,97% |
| 2026-03-02 | Mr. Matthew Craig KapustaCEO & Executive Director | -34,44k | 342,65k | Vente | 9,95 | 455,64k | -7,03% |
| 2026-03-02 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -12,53k | 124,69k | Vente | 9,95 | 109,48k | -10,27% |
| 2026-03-02 | Dr. Jeannette PottsChief Legal & Compliance Officer and Corporate Secretary | -8,58k | 85,35k | Vente | 9,95 | 39,30k | -17,92% |
| 2026-03-02 | Dr. Walid Abi-SaabChief Medical Officer | -1,66k | 16,52k | Vente | 9,95 | 148,78k | -1,10% |
| 2026-02-25 | Mr. Matthew Craig KapustaCEO & Executive Director | -12,38k | 295,34k | Vente | 23,86 | 440,08k | -2,74% |
| 2026-02-25 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -6,22k | 148,34k | Vente | 23,86 | 105,51k | -5,56% |
| 2026-01-12 | Dr. Robert GutNon-Executive Director | -17,81k | 183,94k | Derivative Exercise and Sale | 14,08 - 25,03 | 24,37k | - |
| 2026-01-12 | Dr. Robert GutNon-Executive Director | -7,80k | 195,78k | Automatic Disposition | 25,09 | 24,37k | -24,25% |
| 2026-01-09 | Mr. Jack L. KayeIndependent Non-Executive Director | -6,39k | 50,42k | Derivative Exercise and Sale | 19,39 - 27,28 | 12,47k | - |
| 2025-11-06 | Dr. Robert GutNon-Executive Director | -15,84k | 358,78k | Derivative Exercise and Sale | 4,57 - 27,22 | 32,18k | - |
| 2025-11-06 | Dr. Robert GutNon-Executive Director | -15,59k | 425,72k | Automatic Disposition | 27,30 | 32,18k | -32,64% |
| 2025-11-04 | Mr. Jack L. KayeIndependent Non-Executive Director | -38,81k | 793,98k | Derivative Exercise and Sale | 5,37 - 30,36 | 12,47k | - |
| 2025-09-24 | Mr. Matthew Craig KapustaCEO & Executive Director | -226,32k | 7,91M | Derivative Exercise and Sale | 6,22 - 45,10 | 411,95k | - |
| 2025-09-24 | Mr. Christian KlemtCFO, Principal Financial Officer & GM of Amsterdam Site | -18,00k | 825,48k | Derivative Exercise and Sale | 5,37 - 55,00 | 99,26k | - |
| 2025-06-27 | Dr. Walid Abi-SaabChief Medical Officer | -1,47k | 20,41k | Vente | 13,92 | 150,44k | -0,97% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
